Identification of a breakpoint cluster region 3' of the ribophorin I gene at 3q21 associated with the transcriptional activation of the EVI1 gene in acute myelogenous leukemias with inv(3)(q21q26)Kazumi Suzukawa, Jun Yokota, Evan Parganas et al.|Blood|1994Cited by 147
AP-1, NF-kappa-B, and ERK activation thresholds for promotion of neoplastic transformation in the mouse epidermal JB6 model.Kazumi Suzukawa, Nancy H. Colburn, Thomas J. Weber|Environmental Health Perspectives|2002Cited by 64
EVI-1 zinc finger protein works as a transcriptional activator via binding to a consensus sequence of GACAAGATAAGATAAN1-28 CTCATCTTC.Kazuhiro Morishita, Jun Yokota, Kazumi Suzukawa et al.|PubMed|1995Cited by 46
Identification of a novel fusion gene <i>MLL‐MAML2</i> in secondary acute myelogenous leukemia and myelodysplastic syndrome with inv(11)(q21q23)Noriko Nemoto, Toshiro Nagasawa, Kazumi Suzukawa et al.|Genes Chromosomes and Cancer|2007Cited by 43
Necitumumab plus gemcitabine and cisplatin versus gemcitabine and cisplatin alone as first-line treatment for stage IV squamous non-small cell lung cancer: A phase 1b and randomized, open-label, multicenter, phase 2 trial in JapanSatoshi Watanabe, Tomohide Tamura, Toshiaki Takahashi et al.|Lung Cancer|2019Cited by 38